Risks of ACE Inhibitor and ARB Usage in COVID-19: Evaluating the Evidence - Sriram, Krishna; Insel, Paul A (Clinical pharmacology and therapeutics, 2020)
Keywords: Angiotensin Receptor Antagonists - administration & dosage; Angiotensin Receptor Antagonists - adverse effects; Angiotensin Receptor Antagonists - pharmacology; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors - administration & dosage; Angiotensin-Converting Enzyme Inhibitors - adverse effects; Angiotensin-Converting Enzyme Inhibitors - pharmacology; Animals; Coronavirus Infections - drug therapy; Coronavirus Infections - etiology; COVID-19; Dose-Response Relationship, Drug; Humans; Pandemics; Peptidyl-Dipeptidase A - blood; Peptidyl-Dipeptidase A - metabolism; Peptidyl-Dipeptidase A - urine; Pneumonia, Viral - drug therapy; Pneumonia, Viral - etiology